Vanquish uses ultrasound, transurethral and electromagnetically guided thermotherapy to ablate prostate tissue.

Topical summits in Dubai, Berlin, Nanjing, Basel, Lisbon, London and other cities discussed the uniqueness of Dr Allen's Devices, a new revolutionary medical technology patented in the USA, designed ...

Less than a week after making a regulatory submission for a $1 million capital raise, prostate health company ProUroCare Medical, based in Eden Prairie, Minnesota, announced that it has secured market ...

A drug for advanced prostate cancer has shown "remarkable" results in an early-stage trial, experts have said.

Charlotte, N.C.-based SonaCare Medical earned clearance from the Food and Drug Administration for a new version of its Sonablate device. Sonablate, intended for use in the focused ablation of prostate ...

A DRUG that shrinks tumours in patients with untreatable prostate cancer has shown “remarkable” results, scientists have said. The treatment, called VIR-5500, harnesses the body’s ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Maple Grove-based company ...

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in minimally invasive, focal treatment options has been growing for certain ...

The methods of diagnosing and treating localised prostate cancer has changed significantly in the last two decades.

New prostate cancer drug showing ‘remarkable’ results during clinical trial - The new drug, known as VIR-5500, uses a ...